Pivotal pharmacokinetic trial of a hormone therapy, TX 12002HR, for the treatment of secondary amenorrhoea.
Phase of Trial: Phase I
Latest Information Update: 20 May 2013
At a glance
- Drugs Progesterone (Primary)
- Indications Amenorrhoea
- Focus Pharmacokinetics; Registrational
- 20 May 2013 New trial record
- 01 May 2013 Primary endpoint 'Drug-bioavailability' has been met.